Streetbeat News

CBLL

CeriBell, Inc.

Industry

Healthcare

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Ceribell, Inc. (Nasdaq: CBLL) will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. The company's CFO, Scott Blumberg, will engage in a fireside chat on November 21, 2024.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

Ceribell's point-of-care EEG technology has been shown to reduce hospital stays and improve functional outcomes compared to conventional EEGs. This was highlighted in five abstracts at the 2024 Neurocritical Care Society Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 8:07 pm

CeriBell's IPO shares opened for trading at $23.26, significantly above the IPO price of $17 per share, with a total of 10.61 million shares offered.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:44 pm

The trading halt for an IPO security has been updated, and the security is now released for quotation as of 10:10:00 AM ET.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:10 pm

CeriBell has announced an upsized IPO, pricing 10,606,060 common shares at $17 each, aiming to raise approximately $180.3 million. The shares will trade on Nasdaq under the ticker 'CBLL' starting October 11, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:47 am

CeriBell, Inc is set to go public on October 11, 2023, on the NASDAQ under the ticker CBLL. The IPO price range is $14.00 to $16.00 per share, with a 180-day insider lock-up period.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 3:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.